www.vensanacap.com
Open in
urlscan Pro
141.193.213.20
Public Scan
Submitted URL: http://www.vensanacap.com/
Effective URL: https://www.vensanacap.com/
Submission: On October 04 via api from US — Scanned from DE
Effective URL: https://www.vensanacap.com/
Submission: On October 04 via api from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
Skip to content Vensana hamburger * Our Team * Values * Our Entrepreneurs CAPITAL AND COMMITMENT TO SUPPORT BREAKTHROUGH MEDTECH INNOVATION VENSANA: /'VEN - SAH - NAH : VENTURE + LATIN ROOT FOR "HEALTH" VENSANA CAPITAL℠ IS A VENTURE CAPITAL AND GROWTH EQUITY INVESTMENT FIRM DEDICATED TO PARTNERING WITH ENTREPRENEURS WHO SEEK TO TRANSFORM HEALTHCARE WITH BREAKTHROUGH INNOVATIONS IN MEDICAL TECHNOLOGY. Vensana Capital CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠ Meet Our Team WE HAVE A PASSION FOR MEDICAL TECHNOLOGY INNOVATION. We are guided by our values Vensana is actively investing in development and commercial stage companies across the medtech sector, including medical devices, diagnostics and data science, drug delivery, digital health, life science tools, and tech-enabled services. More About What We Value arrow_left WE CHAMPION OUR ENTREPRENEURS. What Partnership Means to Us Vensana places the highest value on partnering with experienced, insightful, and bold management teams. We hope to invest where our capital and commitment amplifies their success. Meet our entrepreneursarrow_left 34 Level I Clinical Trials 26 Strategic Financings 28 Exits by IPO or M&A 19 Novel FDA PMA & de novo 510k approvals 45 U.S. Commercial Product Launches 34 Level I Clinical Trials 26 Strategic Financings 28 Exits by IPO or M&A 19 Novel FDA PMA & de novo 510k approvals 45 U.S. Commercial Product Launches 34 Level I Clinical Trials ‹› VENSANA CAPITAL CAPITAL PARTNERS FOR HEALTHCARE ENTREPRENEURS℠ READY TO CHANGE HEALTHCARE TOGETHER? CONTACT US TO ARRANGE FOR INVESTMENTS IN DEVELOPMENT AND COMMERCIAL STAGE COMPANIES. Get in Touch OUR LATEST See All News Heart Health Innovator Cleerly Closes Series C Funding Round with $223 Million Moxe Health Raises $30M Series B to Further Advance Interoperability Labcorp Strengthens Oncology Leadership Position With the Addition of Personal Genome Diagnostics Resources News LP Access Contact info@vensanacap.com 612.217.8680 Engage Minneapolis Vensana Capital 3601 W 76th Street Suite 20 Minneapolis, MN 55435 Washington, D.C. Vensana Capital 101 Church Street Suite D Vienna, VA 22180 © 2022 Vensana Capital Management, LLC | Privacy | Terms & Conditions